Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 202

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 202
---
 than 45% of the voting
rights in the company.

These requirements do not
apply if the acquisition (i) occurs in the context of a private placement, provided that the general meeting approved the acquisition
as a private offering whose purpose is to give the acquirer at least 25% of the voting rights in the company if there is no person who
holds at least 25% of the voting rights in the company, or as a private offering whose purpose is to give the acquirer 45% of the voting
rights in the company, if there is no person who holds 45% of the voting rights in the company, (ii) was from a shareholder holding at
least 25% of the voting rights in the company and resulted in the acquirer becoming a holder of at least 25% of the voting rights in
the company, or (iii) was from a holder of more than 45% of the voting rights in the company and resulted in the acquirer becoming a
holder of more than 45% of the voting rights in the company.

The special tender offer
may be consummated only if (i) at least 5% of the voting power attached to the company’s outstanding shares will be acquired by
the offeror and (ii) the special tender offer is accepted by a majority of the votes of those offerees who gave notice of their position
in respect of the offer, excluding the votes of a holder of control in the offeror, a person who has personal interest in acceptance
of the special tender offer, holders of 25% or more of the voting rights in the company or anyone on their behalf, including their relatives
and entities controlled by them.

In the event that a special
tender offer is made, a company’s board of directors is required to express its opinion on the advisability of the offer, or shall
abstain from expressing any opinion if it is unable to do so, provided that it gives the reasons for its abstention. In addition, the
board of directors must disclose any personal interest each member of the board of directors has in the offer or stems therefrom. An
office holder in a target company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause
the failure of an existing or foreseeable special tender offer or is to impair the chances of its acceptance, is liable to the potential
purchaser and shareholders for damages resulting from his or her